| Financial Year |
March 31 2023 |
| Monetary Funds |
402,554,879.09 |
| Held-for-trading Financial Assets |
51,000,000.00 |
| Notes Receivable |
-- |
| Accounts Receivable |
230,629,526.54 |
| Advances to Suppliers |
22,672,619.65 |
| Other Receivables |
21,746,991.19 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
172,129,023.14 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
6,040,932.73 |
| Total Current Assets |
961,553,630.29 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
76,392,485.47 |
| Investment Properties |
43,442,529.72 |
| Fixed Assetes |
225,795,505.65 |
| Under-construction Projects |
42,647,922.61 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
224,427,211.17 |
| R&D expenses |
-- |
| Goodwill |
72,288,569.29 |
| Long-Term Deferred and Prepaid Expenses |
-- |
| Deferred Income Tax Assets |
30,484,682.35 |
| Other Non-Current Assets |
40,449,958.04 |
| Sub-Total of Non-Current Assets |
789,212,733.59 |
| Total Assets |
1,750,766,363.88 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
38,700,000.00 |
| Accounts Payable |
167,211,664.41 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
39,936,404.15 |
| Taxes Payable |
24,464,870.79 |
| Interest Payable |
-- |
| Dividend Payable |
2,400,483.37 |
| Other payables |
78,882,506.59 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
2,754,089.90 |
| Other Current Liabilities |
5,692,004.14 |
| Sub-Total of Current Liabilities |
390,605,702.32 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
40,387,453.96 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
69,092,114.22 |
| Total Liabilities |
459,697,816.54 |
| Paid-In Capital(Or Share Stock) |
200,000,000.00 |
| Capital Surplus |
362,917,106.60 |
| Surplus Reserve |
44,754,476.02 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
481,493,031.43 |
| Minority Stockholder's Interest |
144,336,441.98 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,146,732,105.36 |
| Owner's Equity（Stockholder's Equity） |
1,291,068,547.34 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,750,766,363.88 |
